Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cancer of Gastrointestinal Tract”

3,083 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 3,083 results

Early research (Phase 1)Looking for participantsNCT05176483
What this trial is testing

Study of Zanzalintinib in Combination With Immuno-Oncology Agents in Participants With Solid Tumors

Who this might be right for
Renal Cell Carcinoma (RCC)Metastatic Castration-Resistant Prostate Cancer (mCRPC)Urothelial Carcinoma (UC)+7 more
Exelixis 1,314
Early research (Phase 1)WithdrawnNCT02105350
What this trial is testing

MEK162 With Gemcitabine and Oxaliplatin in Biliary Cancer

Who this might be right for
Biliary Tract CarcinomaGallbladder Carcinoma
University Health Network, Toronto
Not applicableLooking for participantsNCT06528418
What this trial is testing

Identification of Multiple Pulmonary Diseases Using Volatile Organic Compounds Biomarkers in Human Exhaled Breath

Who this might be right for
Lung CancerLung InfectionCOPD+13 more
ChromX Health 10,000
Testing effectiveness (Phase 2)Study completedNCT01917617
What this trial is testing

Oral Rehydration Therapy for Short Hydration in Chemotherapy With CDDP Plus GEM for Biliary Tract Cancer

Who this might be right for
Biliary Tract Cancer
Kansai Hepatobiliary Oncology Group 50
Not applicableStudy completedNCT04532515
What this trial is testing

Seal-G / Seal-G MIST Study

Who this might be right for
Colon CancerGastrointestinal Cancer
Advanced Medical Solutions Ltd. 160
Not applicableUnknownNCT06041815
What this trial is testing

Correlation Between Gut Microbiota and Clinical Response to CAR-T Treatment for Hematological Malignancies

Who this might be right for
Hematological MalignanciesChimeric Antigen Receptor T-cell Therapy
The First Affiliated Hospital of Soochow University 100
Early research (Phase 1)Study completedNCT00199849
What this trial is testing

NY-ESO-1 Plasmid DNA (pPJV7611) Cancer Vaccine

Who this might be right for
Prostate CancerBladder CancerNon-small Cell Lung Cancer+2 more
Ludwig Institute for Cancer Research 18
Not applicableUnknownNCT06115655
What this trial is testing

A Single-center, Prospective Cohort Study on the Differentiation of Benign and Malignant Bile Duct Stenosis Based on Bile and Peripheral Blood cfDNA Methylation Profiles

Who this might be right for
Bile Duct NeoplasmsJaundice, ObstructiveBile Duct Diseases
Air Force Military Medical University, China 161
Not applicableEnrolling By InvitationNCT07050485
What this trial is testing

Postbiotics for Mitigation of Postoperative Dysbiosis in Gastrointestinal Cancer Surgery

Who this might be right for
Colon CancerGastrointestinal Cancer
University of South Florida 30
Very early researchStudy completedNCT01434342
What this trial is testing

Feasibility of Delivering a Quitline Based Smoking Cessation Intervention in Cancer Patients

Who this might be right for
Lung CancerTobacco Use DisorderBreast Cancer+2 more
Wake Forest University Health Sciences 146
Early research (Phase 1)Study completedNCT00666991
What this trial is testing

Pharmacokinetic, Safety and Efficacy Study of Nanoparticle Paclitaxel in Patients With Peritoneal Cancers

Who this might be right for
Peritoneal Neoplasms
CritiTech, Inc. 22
Not applicableUnknownNCT05420259
What this trial is testing

Combined Exercise and Nutritional Intervention in GI Cancer Patients

Who this might be right for
Pancreatic CancerGastric CancerDiet+1 more
Hospital Beatriz Ângelo 68
Testing effectiveness (Phase 2)Ended earlyNCT06024174
What this trial is testing

BMS-986466 With Adagrasib With or Without Cetuximab in Participants With Kirsten Rat Sarcoma Virus Glycine 12 to Cysteine (KRAS G12C)-Mutant Solid Tumors

Who this might be right for
Advanced Solid Tumors
Bristol-Myers Squibb 5
Large-scale testing (Phase 3)Active Not RecruitingNCT03875690
What this trial is testing

Benefit of a Flash Dose of Corticosteroids in Digestive Surgical Oncology: a Randomized, Double Blind, Placebo-controlled Trial

Who this might be right for
Elective Surgery for Any Digestive Cancer
Centre Hospitalier Universitaire Dijon 1,200
Testing effectiveness (Phase 2)Study completedNCT00123825
What this trial is testing

Gemcitabine and Cisplatin for Gallbladder and Biliary Tract Cancer

Who this might be right for
Gallbladder CancerBiliary Tract Cancer
Dana-Farber Cancer Institute 30
Large-scale testing (Phase 3)Study completedNCT00486954
What this trial is testing

Lapatinib in Combination With Weekly Paclitaxel in Patients With ErbB2 Amplified Advanced Gastric Cancer

Who this might be right for
Neoplasms, Gastrointestinal Tract
GlaxoSmithKline 273
Not applicableUnknownNCT02837679
What this trial is testing

Oncogeriatric Intervention and Follow-up at Home

Who this might be right for
NeoplasmsGeriatric AssessmentLung Neoplasms+6 more
Aarhus University Hospital 350
Testing effectiveness (Phase 2)Active Not RecruitingNCT04699188
What this trial is testing

Study of JDQ443 in Patients With Advanced Solid Tumors Harboring the KRAS G12C Mutation

Who this might be right for
KRAS G12C Mutant Solid TumorsCarcinoma, Non-Small-Cell LungCarcinoma, Colorectal+7 more
Novartis Pharmaceuticals 344
Large-scale testing (Phase 3)Study completedNCT00270166
What this trial is testing

The Effect of Epoetin Alfa on the Anemia of Patients With Selected Cancers Receiving Chemotherapy

Who this might be right for
AnemiaMultiple MyelomaLymphoma+6 more
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 201
Early research (Phase 1)Study completedNCT02451553
What this trial is testing

Afatinib Dimaleate and Capecitabine in Treating Patients With Advanced Refractory Solid Tumors, Pancreatic Cancer or Biliary Cancer

Who this might be right for
Advanced Malignant Solid NeoplasmBile Duct CarcinomaRecurrent Malignant Solid Neoplasm+4 more
University of Washington 41
Load More Results